Literature DB >> 10868648

Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.

I M Kidd1, D A Clark, C A Sabin, D Andrew, A F Hassan-Walker, P Sweny, P D Griffiths, V C Emery.   

Abstract

BACKGROUND: Human herpesvirus 6 (HHV-6) and HHV-7 are two lymphotropic herpesviruses, which, like cytomegalovirus (CMV), have the potential to be pathogenic in immunocompromised individuals. We have conducted a prospective investigation to compare the natural history of HHV-6 and HHV-7 infection with that of CMV after renal transplantation.
METHODS: Polymerase chain reaction was used to identify infections and quantify the viral load of CMV, HHV-6, and HHV-7 in peripheral blood samples from 52 renal transplant recipients. Betaherpesvirus infections were related to defined clinical criteria obtained by detailed examination of the clinical records of each patient for the immediate 120-day posttransplant period.
RESULTS: CMV was the most commonly detected virus after transplant (58% of patients), followed by HHV-7 (46%) and HHV-6 (23%). Examining the time to first polymerase chain reaction positivity, HHV-7 infection was detected earlier than CMV (P=0.05). The median maximum CMV viral load was significantly higher than those for HHV-6 (P=0.01) and HHV-7 (P<0.0001) and a trend for HHV-7 viral load to be greater than HHV-6 (P=0.08). Clinicopathological analyses revealed that, in those patients with rejection, HHV-7 was associated with more episodes of rejection (P=0.02). In addition, there was a significant increase in CMV disease occurring in patients with CMV and HHV-7 co-infection compared to those with CMV infection only (P=0.04).
CONCLUSIONS: HHV-7 should be further investigated as a possible co-factor in the development of CMV disease in renal transplant patients and may potentially exacerbate graft rejection. No clear pathological role was observed for HHV-6.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868648     DOI: 10.1097/00007890-200006150-00032

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  26 in total

1.  Recent Advances in the Management of Infections in Liver Transplant Recipients.

Authors:  Nina Singh
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 2.  Viral infections in lung transplant recipients.

Authors:  Pali Dedhiya Shah; John F McDyer
Journal:  Semin Respir Crit Care Med       Date:  2010-03-30       Impact factor: 3.119

3.  Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.

Authors:  Andrea Lisco; Jean-Charles Grivel; Angélique Biancotto; Christophe Vanpouille; Francesco Origgi; Mauro S Malnati; Dominique Schols; Paolo Lusso; Leonid B Margolis
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Detection of human herpesvirus 7 DNA by loop-mediated isothermal amplification.

Authors:  Tetsushi Yoshikawa; Masaru Ihira; Shiho Akimoto; Chie Usui; Fumi Miyake; Sadao Suga; Yoshihiko Enomoto; Ryota Suzuki; Yukihiro Nishiyama; Yoshizo Asano
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.

Authors:  Shara N Pantry; Maria M Medveczky; Jesse H Arbuckle; Janos Luka; Jose G Montoya; Jianhong Hu; Rolf Renne; Daniel Peterson; Joshua C Pritchett; Dharam V Ablashi; Peter G Medveczky
Journal:  J Med Virol       Date:  2013-07-25       Impact factor: 2.327

Review 7.  Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials.

Authors:  Joshua A Hill; Danielle M Zerr
Journal:  Curr Opin Virol       Date:  2014-10-04       Impact factor: 7.090

Review 8.  Viral infection after renal transplantation: surveillance and management.

Authors:  Blair C Weikert; Emily A Blumberg
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

9.  Human Herpesvirus 6 Infection in Pediatric Liver Transplantation: Single-Center Study of Incidence, Outcomes, and Management.

Authors:  Krupa R Mysore; Tuan L Phan; Ryan W Himes; Deborah Schady; Karen W Eldin; Bhupesh K Prusty; Flor M Munoz
Journal:  J Pediatric Infect Dis Soc       Date:  2021-05-28       Impact factor: 3.164

Review 10.  Cytomegalovirus infection in critically ill patients: a systematic review.

Authors:  Ryosuke Osawa; Nina Singh
Journal:  Crit Care       Date:  2009-05-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.